Medpace Holdings (MEDP) Assets Average (2016 - 2026)
Medpace Holdings' (MEDP) quarterly Assets Average came in at $2.1 billion in Q2 2026, up 20.69% on a YoY basis from $1.7 billion in Q2 2025, and up 1.99% quarter-over-quarter from $2.1 billion in Q1 2026.
Analysis
Medpace Holdings (MEDP) Assets Average (2016 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Assets Average for 11 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 20.69% year-over-year to $2.1 billion; the trailing twelve-month figure through Jun 2026 stood at $2.1 billion (up 20.69% YoY), and the FY2025 full-year result was $2.0 billion, up 8.48% from the prior year.
- Assets Average climbed to $2.1 billion in Q2 2026 per MEDP's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.1 billion in Q2 2026 and bottomed at $1.3 billion in Q3 2022.
- Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average fell 17.18% in 2022, then jumped 38.38% in 2024.
- Over 5 years, Assets Average stood at $1.3 billion in 2022, then rose by 17.26% to $1.6 billion in 2023, then jumped by 33.13% to $2.1 billion in 2024, then fell by 10.91% to $1.9 billion in 2025, then gained by 12.29% to $2.1 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $2.1 billion, $2.1 billion, and $1.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 29.78 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 2.09 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 16.36 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 7.63 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.70 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.87 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 1.01 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 30.14 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 14.01 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 5.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Bn |
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 1.86 Bn |
| Sep 30, 2025 | 1.66 Bn |
| Jun 30, 2025 | 1.73 Bn |
| Mar 31, 2025 | 2.00 Bn |
| Dec 31, 2024 | 2.09 Bn |
| Sep 30, 2024 | 2.00 Bn |
| Jun 30, 2024 | 1.86 Bn |
| Mar 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.45 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 1.32 Bn |
| Jun 30, 2022 | 1.33 Bn |
| Mar 31, 2022 | 1.50 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.52 Bn |